marijuana stocks news

Terra Tech Corp. (TRTC)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 1,507   1,315   3,712   560  
Cost of Revenue 1,321 1,251 3,811 558
Gross Profit 187   64   (100) 2  
Operating Expenses
Research Development
Selling General and Administrative 4,197 8,035 3,892 2,204
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (4,010) (7,971) (3,992) (2,202)
Income from Continuing Operations
Total Other Income/Expenses Net 1,094 (1,162) (329) (2,499)
Earnings Before Interest And Taxes (2,916) (9,134) (4,321) (4,701)
Interest Expense 258 388 234 216
Income Before Tax (3,174) (9,521) (4,555) (4,916)
Income Tax Expense 13
Minority Interest 291
Net Income From Continuing Ops (2,896) (9,521) (4,555) (4,916)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (2,896) (9,521) (4,555) (4,916)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (2,896) (9,521) (4,555) (4,916)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) Submits Supplemental New Drug Application to U.S. FDA

AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™)…

$FULL Provides Update on Fourth Quarter Fiscal 2015 Portfolio Activity

Full Circle Capital Provides Update on Fourth Quarter Fiscal 2015 Portfolio Activity…

Tetra Bio-Pharma Inc. (TBPMF) Enters into a Strategic Partnership with Avicanna

Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna Tetra Bio-Pharma Inc.…

$CARA to Present Data at the 8th World Congress on Itch

Cara Therapeutics to Present Data at the 8th World Congress on Itch…